A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.
People born recently in England and Wales can expect to spend fewer years of their life in good health than those born over a decade ago, official figures show.
Recent Comments